Acer therapeutics reports q2 loss per share $0.56

Acer therapeutics reports second quarter 2020 financial results and provides corporate update.q2 loss per share $0.56.q2 earnings per share estimate $-0.38 -- refinitiv ibes data.

ACER Ratings Summary

Quant